Atlas Trials

A Study to Evaluate the Absorption, Metabolism, and Excretion and Absolute Bioavailability of Xevinapant in Healthy Male Participants

Clinical trial NCT04962724 · COMPLETED

Trial details

NCT number
NCT04962724
Sponsor
Debiopharm International SA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2021-08-02
Primary completion
2021-11-09
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.